July 2024 – Page 273 – Get News Story

Pyelonephritis Clinical Trials Analysis 2024: FDA Approvals, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight

“Pyelonephritis Clinical Trials”

Pyelonephritis companies are Wockhardt, Sinovent, Entasis Therapeutics, Melinta Therapeutics, Allecra Therapeutics GmbH, Entasis Therapeutics Holdings Inc, Iterum Therapeutics Plc, Jiangsu Sinoyoung Bio-Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd, Merck & Co Inc, MerLion Pharmaceuticals Pte Ltd, Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc, Pfizer Inc, Qilu Pharmaceutical Co Ltd, VenatoRx Pharmaceuticals Inc, XuanZhu Biological Technology Co Ltd and others.

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Pyelonephritis pipeline constitutes 20+ key companies continuously working towards developing 20+ Pyelonephritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Pyelonephritis Pipeline Insight, 2024″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pyelonephritis Market.

The Pyelonephritis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Request for Sample Report here @ Pyelonephritis Pipeline Analysis

Some of the key takeaways from the Pyelonephritis Pipeline Report:

Pyelonephritis Companies across the globe are diligently working toward developing novel Pyelonephritis treatment therapies with a considerable amount of success over the years.
Pyelonephritis companies working in the treatment market are Wockhardt, Sinovent, Entasis Therapeutics, Melinta Therapeutics, Allecra Therapeutics GmbH, Entasis Therapeutics Holdings Inc, Iterum Therapeutics Plc, Jiangsu Sinoyoung Bio-Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd, Merck & Co Inc, MerLion Pharmaceuticals Pte Ltd, Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc, Pfizer Inc, Qilu Pharmaceutical Co Ltd, VenatoRx Pharmaceuticals Inc, XuanZhu Biological Technology Co Ltd and others, are developing therapies for the Pyelonephritis treatment.
Emerging Pyelonephritis therapies such as WCK-5222, XNW 4107, ETX2514SUL and others are expected to have a significant impact on the Pyelonephritis market in the coming years.
On December 2023, Wockhardt announced results of a Phase 3, Randomized, Double-blind, Multicenter, Comparative Study to Determine the Efficacy and Safety of Cefepime-zidebactam vs. Meropenem in the Treatment of Complicated Urinary Tract Infection or Acute Pyelonephritis in Adults.
On June 2023, Meiji Seika Pharma Co., Ltd announced results of a Phase 3, Multi-Center, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis, in Adults.

Pyelonephritis Overview

Pyelonephritis is a bacterial infection of the kidneys, typically stemming from a urinary tract infection (UTI) that ascends to the kidneys. It commonly affects women and can occur suddenly (acute pyelonephritis) or develop gradually (chronic pyelonephritis). The most common causative agent is Escherichia coli, though other bacteria can also be responsible.

Symptoms of pyelonephritis may include fever, chills, flank pain (pain in the side or back), nausea, vomiting, and frequent urination. In severe cases, individuals may experience confusion or symptoms of sepsis, a life-threatening condition characterized by systemic inflammation in response to infection.

Pyelonephritis Diagnosis typically involves a physical examination, urinalysis, urine culture, and imaging studies such as ultrasound, CT scan, or MRI to assess kidney involvement and rule out complications like abscess formation or kidney stones.

Pyelonephritis Treatment often involves antibiotics to eradicate the bacterial infection. In severe cases or those involving complications, hospitalization may be necessary for intravenous antibiotic therapy and supportive care. Adequate hydration is important to help flush out bacteria from the urinary tract. Patients may also require pain management and medications to alleviate fever and discomfort.

Untreated or recurrent pyelonephritis can lead to complications such as kidney damage, abscess formation, sepsis, or even kidney failure, emphasizing the importance of prompt diagnosis and treatment. Additionally, preventive measures such as good hygiene, proper hydration, and prompt treatment of UTIs can help reduce the risk of developing pyelonephritis.

Get a Free Sample PDF Report to know more about Pyelonephritis Pipeline Therapeutic Assessment- Pyelonephritis Treatment Market

Pyelonephritis Route of Administration

Pyelonephritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Intra-articular
Intraocular
Intrathecal
Intravenous
Ophthalmic
Oral
Parenteral
Subcutaneous
Topical
Transdermal

Pyelonephritis Molecule Type

Pyelonephritis Products have been categorized under various Molecule types, such as

Oligonucleotide
Peptide
Small molecule

Pyelonephritis Pipeline Therapeutics Assessment

Pyelonephritis Assessment by Product Type
Pyelonephritis By Stage and Product Type
Pyelonephritis Assessment by Route of Administration
Pyelonephritis By Stage and Route of Administration
Pyelonephritis Assessment by Molecule Type
Pyelonephritis by Stage and Molecule Type

DelveInsight’s Pyelonephritis Pipeline Report covers around 20+ products under different phases of clinical development like-

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Pyelonephritis product details are provided in the report. Download the Pyelonephritis pipeline report to learn more about the emerging Pyelonephritis therapies- Pyelonephritis Clinical Trials and FDA Approvals

Pyelonephritis Pipeline Analysis:

The Pyelonephritis pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Pyelonephritis with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Pyelonephritis Treatment.
Pyelonephritis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Pyelonephritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Pyelonephritis market.

Download Sample PDF Report to know more about Pyelonephritis drugs and therapies- Pyelonephritis Clinical Trials and FDA Approvals

Scope of Pyelonephritis Pipeline Drug Insight

Coverage: Global
Key Pyelonephritis Companies: Wockhardt, Sinovent, Entasis Therapeutics, Melinta Therapeutics, Allecra Therapeutics GmbH, Entasis Therapeutics Holdings Inc, Iterum Therapeutics Plc, Jiangsu Sinoyoung Bio-Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd, Merck & Co Inc, MerLion Pharmaceuticals Pte Ltd, Nabriva Therapeutics Plc, Paratek Pharmaceuticals Inc, Pfizer Inc, Qilu Pharmaceutical Co Ltd, VenatoRx Pharmaceuticals Inc, XuanZhu Biological Technology Co Ltd and others.
Key Pyelonephritis Therapies: WCK-5222, XNW 4107, ETX2514SUL and others.
Pyelonephritis Therapeutic Assessment: Pyelonephritis current marketed and Pyelonephritis emerging therapies
Pyelonephritis Market Dynamics: Pyelonephritis market drivers and Pyelonephritis market barriers

Request for Sample PDF Report for Pyelonephritis Pipeline Assessment and clinical trials – Pyelonephritis Therapeutics Market

Table of Contents

1. Pyelonephritis Report Introduction

2. Pyelonephritis Executive Summary

3. Pyelonephritis Overview

4. Pyelonephritis- Analytical Perspective In-depth Commercial Assessment

5. Pyelonephritis Pipeline Therapeutics

6. Pyelonephritis Late Stage Products (Phase II/III)

7. Pyelonephritis Mid Stage Products (Phase II)

8. Pyelonephritis Early Stage Products (Phase I)

9. Pyelonephritis Preclinical Stage Products

10. Pyelonephritis Therapeutics Assessment

11. Pyelonephritis Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Pyelonephritis Companies

14. Pyelonephritis Key Products

15. Pyelonephritis Unmet Needs

16 . Pyelonephritis Market Drivers and Barriers

17. Pyelonephritis Future Perspectives and Conclusion

18. Pyelonephritis Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432, Las Vegas NV 89107
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pyelonephritis Clinical Trials Analysis 2024: FDA Approvals, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight

Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Analysis 2024: FDA Approvals, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight

“Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials”

Non Alcoholic Fatty Liver Disease (NAFLD) companies are Eli Lilly and Company, AstraZeneca, Oasis Pharmaceuticals, LLC, BioMarin Pharmaceutical, GlaxoSmithKline, Zydus Therapeutics Inc., Akero Therapeutics, Inc, Pfizer, Boehringer Ingelheim, Neuraly, Inc., Merck Sharp & Dohme LLC, Rivus Pharmaceuticals, Inc., Guangdong Raynovent Biotech, Dr. Falk Pharma GmbH, Enyo Pharma, Viking Therapeutics, Terns, Hepion Pharmaceuticals, Poxel, Galectin Therapeutics, AngioLabs, MediciNova and others.

(Albany, United States) As per DelveInsight’s assessment, globally, Non Alcoholic Fatty Liver Disease (NAFLD) pipeline constitutes 80+ key companies continuously working towards developing 100+ Non Alcoholic Fatty Liver Disease (NAFLD) treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Insight, 2024″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Non Alcoholic Fatty Liver Disease (NAFLD) Market.

The Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Request for Sample Report here @ Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Analysis

Some of the key takeaways from the Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Report:

NAFLD Companies across the globe are diligently working toward developing novel Non Alcoholic Fatty Liver Disease (NAFLD) treatment therapies with a considerable amount of success over the years.
Non Alcoholic Fatty Liver Disease (NAFLD) companies working in the treatment market are Eli Lilly and Company, AstraZeneca, Oasis Pharmaceuticals, LLC, BioMarin Pharmaceutical, GlaxoSmithKline, Zydus Therapeutics Inc., Akero Therapeutics, Inc, Pfizer, Boehringer Ingelheim, Neuraly, Inc., Merck Sharp & Dohme LLC, Rivus Pharmaceuticals, Inc., Guangdong Raynovent Biotech, Dr. Falk Pharma GmbH, Enyo Pharma, Viking Therapeutics, Sagimet Biosciences, Terns, Sinew Pharma, Hepion Pharmaceuticals, Poxel, Galectin Therapeutics, AngioLabs, MediciNova and others, are developing therapies for the Non Alcoholic Fatty Liver Disease (NAFLD) treatment.
Emerging Non Alcoholic Fatty Liver Disease (NAFLD) therapies such as MN-001, LY3885125, AZD7503, Lanifibranor, OA-235i, Resmetirom, BMN 255, GSK4532990, Saroglitazar Magnesium 4 mg Tablet, Efruxifermin, PF-06865571, BI 3006337, DD01, Efinopegdutide, HU6, Rencofilstat, and others are expected to have a significant impact on the Non Alcoholic Fatty Liver Disease (NAFLD) market in the coming years.
On April 2024, Akero Therapeutics, Inc announced results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
On December 2023, Madrigal Pharmaceuticals, Inc announced results of a 52-Week, Phase 3, Open-Label Extension Study, With a Double-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Non Alcoholic Fatty Liver Disease (NAFLD) Overview

Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition characterized by the accumulation of fat in the liver of individuals who consume little to no alcohol. NAFLD encompasses a spectrum of liver conditions, ranging from simple fatty liver (steatosis) to more severe forms like non-alcoholic steatohepatitis (NASH), which involves inflammation and liver cell damage. Risk factors for NAFLD include obesity, insulin resistance, type 2 diabetes, high cholesterol, and metabolic syndrome. The exact cause of NAFLD is not fully understood but is believed to involve a combination of genetic, environmental, and lifestyle factors.

NAFLD often presents without noticeable symptoms in its early stages, but as the condition progresses, individuals may experience fatigue, abdominal discomfort, and enlargement of the liver. Diagnosis typically involves imaging studies such as ultrasound, CT scan, or MRI, along with blood tests to assess liver function and rule out other liver diseases.

Management of NAFLD primarily focuses on lifestyle interventions, including weight loss, regular exercise, and dietary changes aimed at reducing fat accumulation in the liver and improving metabolic health. For individuals with NASH or advanced NAFLD, additional treatments such as medications targeting liver inflammation or fibrosis may be considered. Close monitoring and management of NAFLD are essential to prevent progression to more severe liver complications, including cirrhosis and liver failure.

Get a Free Sample PDF Report to know more about Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Therapeutic Assessment @ Non Alcoholic Fatty Liver Disease (NAFLD) Treatment Market

Non Alcoholic Fatty Liver Disease (NAFLD) Route of Administration

Non Alcoholic Fatty Liver Disease (NAFLD) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Intravenous
Subcutaneous
Parenteral
Topical

Non Alcoholic Fatty Liver Disease (NAFLD) Molecule Type

Non Alcoholic Fatty Liver Disease (NAFLD) Products have been categorized under various Molecule types, such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Therapeutics Assessment

Non Alcoholic Fatty Liver Disease (NAFLD) Assessment by Product Type
Non Alcoholic Fatty Liver Disease (NAFLD) By Stage and Product Type
Non Alcoholic Fatty Liver Disease (NAFLD) Assessment by Route of Administration
Non Alcoholic Fatty Liver Disease (NAFLD) By Stage and Route of Administration
Non Alcoholic Fatty Liver Disease (NAFLD) Assessment by Molecule Type
Non Alcoholic Fatty Liver Disease (NAFLD) by Stage and Molecule Type

DelveInsight’s Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Report covers around 100+ products under different phases of clinical development like-

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Non Alcoholic Fatty Liver Disease (NAFLD) product details are provided in the report. Download the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline report to learn more about the emerging Non Alcoholic Fatty Liver Disease (NAFLD) therapies @ Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials and FDA Approvals

Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Analysis:

The Non Alcoholic Fatty Liver Disease (NAFLD) pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Non Alcoholic Fatty Liver Disease (NAFLD) with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Non Alcoholic Fatty Liver Disease (NAFLD) Treatment.
Non Alcoholic Fatty Liver Disease (NAFLD) key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Non Alcoholic Fatty Liver Disease (NAFLD) Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Non Alcoholic Fatty Liver Disease (NAFLD) market.

Download Sample PDF Report to know more about Non Alcoholic Fatty Liver Disease (NAFLD) drugs and therapies @ Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Market

Scope of Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Drug Insight

Coverage: Global
Key Non Alcoholic Fatty Liver Disease (NAFLD) Companies: Eli Lilly and Company, AstraZeneca, Oasis Pharmaceuticals, LLC, BioMarin Pharmaceutical, GlaxoSmithKline, Zydus Therapeutics Inc., Akero Therapeutics, Inc, Pfizer, Boehringer Ingelheim, Neuraly, Inc., Merck Sharp & Dohme LLC, Rivus Pharmaceuticals, Inc., Guangdong Raynovent Biotech, Dr. Falk Pharma GmbH, Enyo Pharma, Viking Therapeutics, Sagimet Biosciences, Terns, Sinew Pharma, Hepion Pharmaceuticals, Poxel, Galectin Therapeutics, AngioLabs, MediciNova and others.
Key Non Alcoholic Fatty Liver Disease (NAFLD) Therapies: MN-001, LY3885125, AZD7503, Lanifibranor, OA-235i, Resmetirom, BMN 255, GSK4532990, Saroglitazar Magnesium 4 mg Tablet, Efruxifermin, PF-06865571, BI 3006337, DD01, Efinopegdutide, HU6, Rencofilstat, and others.
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutic Assessment: Non Alcoholic Fatty Liver Disease (NAFLD) current marketed and Non Alcoholic Fatty Liver Disease (NAFLD) emerging therapies
Non Alcoholic Fatty Liver Disease (NAFLD) Market Dynamics: Non Alcoholic Fatty Liver Disease (NAFLD) market drivers and Non Alcoholic Fatty Liver Disease (NAFLD) market barriers

Request for Sample PDF Report for Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Assessment and clinical trials @ Non Alcoholic Fatty Liver Disease (NAFLD) Drugs and Therapies

Table of Contents

Non Alcoholic Fatty Liver Disease (NAFLD) Report Introduction
Non Alcoholic Fatty Liver Disease (NAFLD) Executive Summary
Non Alcoholic Fatty Liver Disease (NAFLD) Overview
Non Alcoholic Fatty Liver Disease (NAFLD)- Analytical Perspective In-depth Commercial Assessment
Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Therapeutics
Non Alcoholic Fatty Liver Disease (NAFLD) Late Stage Products (Phase II/III)
Non Alcoholic Fatty Liver Disease (NAFLD) Mid Stage Products (Phase II)
Non Alcoholic Fatty Liver Disease (NAFLD) Early Stage Products (Phase I)
Non Alcoholic Fatty Liver Disease (NAFLD) Preclinical Stage Products
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics Assessment
Non Alcoholic Fatty Liver Disease (NAFLD) Inactive Products
Company-University Collaborations (Licensing/Partnering) Analysis
Non Alcoholic Fatty Liver Disease (NAFLD) Companies
Non Alcoholic Fatty Liver Disease (NAFLD) Key Products
Non Alcoholic Fatty Liver Disease (NAFLD) Unmet Needs
16 . Non Alcoholic Fatty Liver Disease (NAFLD) Market Drivers and Barriers
Non Alcoholic Fatty Liver Disease (NAFLD) Future Perspectives and Conclusion
Non Alcoholic Fatty Liver Disease (NAFLD) Analyst Views
Appendix
About DelveInsight

About DelveInsight

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Analysis 2024: FDA Approvals, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight

The Dairy Alliance and Publix Fuel Runners at Peachtree Health & Fitness Expo

Provides attendees with nutrient-rich and refreshing dairy milk at Peachtree Health & Fitness Expo

The Dairy Alliance, a nonprofit funded by dairy farmers in the Southeast, is teaming up with Publix to hydrate and fuel up runners at the Peachtree Health & Fitness Expo presented by Publix at the Georgia World Congress Center in Atlanta. The Dairy Alliance will distribute over 6,000 bottles of chocolate dairy milk, generously provided by Publix. Attendees are encouraged to visit The Dairy Alliance exhibit in Hall C4 at Booth #410 from July 2 to 3, 2024, between 10 a.m. and 6 p.m.

Research supports that dairy milk is one of the best beverages for hydration, outperforming water, and sports drinks. The Dairy Alliance’s team members will be onsite to educate attendees firsthand about dairy milk’s hydration benefits leading up to the AJC Peachtree Road Race on July 4.

“We are thrilled to be working with Publix again and supporting runners as they prepare for the world’s largest 10K race,” Geri Berdak, Chief Executive Officer at The Dairy Alliance. “Our focus is to help all 60,000 plus runners have their best day through the powerful benefits of dairy milk which includes hydration and recovery, and we are honored to be part of such a significant event in the Atlanta area.”

Expo attendees are invited to connect with Marie Spano, MS, RD, CSCS, CSSD, a renowned sports nutritionist and nutrition communications expert. Spano will be a panelist at this year’s Expo where attendees can meet her at The Dairy Alliance Booth #410 in person.

“This is an excellent opportunity for attendees to discover how dairy milk can support their peak performance and recovery,” said Spano. “I’m looking forward to speaking on this year’s panel and representing The Dairy Alliance as we connect with runners leading up to race day.”

The Expo will be open to the public, where attendees can stop by and grab a complimentary bottle of refreshing chocolate milk, cooling towels, cowbells, and stickers.

The AJC Peachtree Road Race is part of the lead-up to Every Woman’s Marathon, an initiative by MilkPEP. The Dairy Alliance is dedicated to supporting women and their races. Join #TEAMMILK by signing up for Every Woman’s Marathon as a runner or supporter.

Learn more at https://everywomansmarathon.com. For more information about The Dairy Alliance, visit https://thedairyalliance.com or follow them on Facebook or Instagram @TheDairyAlliance.

About The Dairy Alliance

The Dairy Alliance is a nonprofit funded by the Southeast dairy farm families. We work diligently with dairy farmers, schools, sports teams, health professionals, local organizations, state leaders, the media, and the public to promote dairy foods and knowledge about the dairy industry. Our efforts centre in eight states: Alabama, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, and Virginia.

Social Media:

Facebook: @thedairyalliance

Instagram:@thedairyalliance/

LinkedIn: https://www.linkedin.com/company/thedairyalliance/

Media Contact
Company Name: Ink Link Marketing
Contact Person: Kaitlyn Ianiro
Email: Send Email
Phone: 305.631.2283
City: Sioux Falls
State: South Dakota
Country: United States
Website: http://www.nekterjuicebar.com/

CRYPTOMMS LTD. (CRYPTOMMS EXCHANGE cryptomms.com) has recently successfully filed with the SEC and launched multiple public welfare projects

Renowned company CRYPTOMMS LTD. recently completed a successful filing with the U.S. Securities and Exchange Commission (SEC) and obtained the Reg D exemption. CRYPTOMMS LTD. fully complied with SEC requirements and smoothly completed the filing process. This result marks an important milestone in CRYPTOMMS’s compliance process and enhances its brand authority.

Headquartered in the United States, CRYPTOMMS LTD. is an AI-driven centralized cryptocurrency exchange and wallet platform, known as CRYPTOMMS. The company is committed to providing quality services to millions of customers worldwide. Recently, CRYPTOMMS announced the launch of a series of public welfare projects aimed at fulfilling social responsibilities and promoting the continuous development of the industry.

https://www.sec.gov/edgar/browse/?CIK=2024131

CRYPTOMMS LTD. actively fulfills its social responsibilities by engaging in various forms of public welfare activities. The company not only donates urgently needed supplies to impoverished communities but also actively participates in environmental protection and sustainable development projects. Additionally, CRYPTOMMS strongly supports education by providing AI-enabled electronic devices to schools in poor areas, using AI technology to improve educational conditions.

The CRYPTOMMS team brings together outstanding blockchain technology experts from around the world, with core members having worked at globally renowned fintech companies. With business operations spanning over 30 countries, CRYPTOMMS has established a good reputation in many countries through innovative products, exploring new trading methods, and providing quality services.

To fulfill its social responsibilities, CRYPTOMMS has undertaken the following public welfare activities:

• Donated AI-enabled electronic devices to schools in impoverished areas.

• Conducted lectures to popularize knowledge of blockchain technology and AI.

• Promoted the application of blockchain technology in green energy management and carbon emission monitoring.

• Provided funding to inspire young people’s interest in blockchain and AI technologies.

• Announced that a portion of its revenue would be donated to charitable organizations to support various social welfare causes, improve social welfare, and promote social equity.

The core of the CRYPTOMMS trading system lies in its powerful data analysis and processing capabilities. Utilizing technologies such as machine learning and deep learning, the CRYPTOMMS trading system can continuously learn and optimize trading strategies, thereby improving the accuracy and efficiency of trading. The system can automatically execute trades and operate according to preset rules, reducing human factors in trading decisions and enhancing trading stability and consistency.

The CRYPTOMMS AI intelligent trading system uses automated methods to acquire and analyze massive amounts of market data to better capture market changes. The system can monitor market dynamics in real-time, identify potential trading opportunities, and respond quickly. Compared to traditional manual trading, the AI intelligent trading system has faster decision-making speed and a broader range of information coverage, enabling more accurate market insights.

Driven by the AI wave, CRYPTOMMS actively participates in promoting informatization in impoverished areas. The company provides laptops and smartphones to these regions, supports financial inclusion projects, and offers technical support, enabling local residents to access online financial and other network resources. This not only helps those who lack access to traditional financial services but also promotes financial inclusion and sustainable development.

Through these efforts, residents of impoverished areas are integrated into the information society and have the opportunity to learn about AI and blockchain technology. Meanwhile, CRYPTOMMS has carried out a series of digital literacy training activities to improve the information literacy of local residents. These initiatives aim to promote the development of AI and financial inclusion, allowing more people to enjoy the benefits and opportunities brought by AI and blockchain, contributing to the construction of an information society.

CRYPTOMMS hopes to fulfill its social responsibilities through these public welfare activities, contribute to industry development, and benefit more people.

Media Contact
Company Name: CRYPTOMMS LTD.
Contact Person: JOSEPH C KILRAIN
Email: Send Email
Country: United States
Website: https://office.cryptomms.com

LiTime Announces 2024 Prime Day Event Amid Global Energy Transition

Shenzhen, China – Renowned for its lithium iron phosphate (LiFePO4) batteries, energy brand LiTime has announced the launch of its 2024 Prime Day event. This initiative, aimed at promoting new energy storage solutions and enhancing user benefits, will run from July 16 to July 17. During this period, customers can log into the LiTime website to enjoy Amazon Prime-like prices without needing an Amazon Prime membership. Additionally, the LiTime website will offer double points for eligible purchases to its valued website members.

Global Energy Transition

According to the World Meteorological Organization’s (WMO) 2023 State of the Global Climate report, the growth rate of renewable energy capacity worldwide has reached its highest speed observed in the past two decades, marking the beginning of a substantial energy transition. While harnessing renewable energy from nature is crucial, efficiently and reliably storing this energy is equally important. Lithium iron phosphate, a chemical material used in manufacturing lithium-ion batteries, is renowned for its high safety, efficiency, and environmental friendliness. It is suitable for renewable energy, household, and portable electronic device storage, making it widely applicable for personal use.

Versatile Application Needs

Beyond understanding the inherent advantages of lithium iron phosphate, individuals may encounter various scenarios when using batteries made from this material, such as water-based, land-based, and household scenarios. LiTime, driven by user needs, has designed and developed multiple lithium iron phosphate batteries suitable for different scenarios to meet diverse user requirements.

For Water-Based Scenarios: 12V 100Ah TM Battery for Trolling Motors

Prime Day Price: $254.98 (Original Price: $539.99, 47% Discount)
Description: Designed for avid fishing enthusiasts, this battery provides quick and reliable power delivery for trolling motors. Engineered for harsh environments, it features an IP65 waterproof rating and 1280Wh of usable energy, suitable for 30-70 lbs trolling motors. It supports a maximum discharge current of 300A to 500A for 5 seconds, ensuring smoother and more precise control of trolling motors for more effective fishing.
Other recommended batteries for this scenario:

o Motor thrust 70-100 lbs: 24V 100Ah Bluetooth $531 (Original Price: $869.99, 61% Discount)

o Motor thrust 100-120 lbs: 36V 55Ah TM $449.99 (Original Price: $666.66, 67% Discount)

For Land-Based Scenarios: 12V 100Ah Group24 Bluetooth Battery for RVs

Prime Day Price: $279.99 (Original Price: $579.99, 48% Discount)
Description: Designed for professional RV travelers, this battery reduces storage space by up to 25% compared to a 12V 100Ah lead-acid battery while delivering 200% more energy. Paired with LiTime’s intelligent Bluetooth 5.0, it allows real-time monitoring of the battery’s overall status and data through the LiTime app, including SOC, charge/discharge/idle status, voltage, current, power, remaining capacity, temperature, and life cycle.
Other recommended batteries for this scenario:

o 12V 230Ah Plus, Low-Temp $557.99 (Original Price: $849.99, 65% Discount)

o 12V 280Ah Plus, Low-Temp $638.99 (Original Price: $1014.27, 62% Discount)

o 12V 460Ah $1199.99 (Original Price: $2099.99, 57% Discount)

o For larger RVs, higher voltage batteries are needed: 24V 230Ah $1999.99 (Original Price: $1119.99, 55% Discount)

For Home Energy Storage: 51.2V 100Ah Battery

Prime Day Price: $1259.99 (Original Price: $2169.99, 58% Discount)
Description: Providing a practical solution for off-grid living, this battery offers 5120Wh of energy and supports 4P, utilizing premium lithium cells to store a large amount of clean energy. It can power a 120W refrigerator continuously for 42.6 hours. LiTime is committed to providing safe and green power systems, with a product design that emphasizes environmental friendliness, contributing to the reduction of carbon emissions even in household power use.

New Product Announcements

LiTime, with a robust R&D team, is a truly user-driven innovation brand. Based on feedback from over 30,000 users, they have developed more multi-scenario batteries, providing users with more efficient and environmentally friendly energy solutions.

New 12V 100Ah Marine Outboard Motor Battery

Description: Designed to support 5P5S configurations, this versatile battery is expandable to suit 24V, 36V, 48V, and 60V electric outboard motors. Featuring EV Grade-A cells, one unit of this battery is equivalent to two 12V 100Ah lead-acid batteries. It fits the Group31 size, seamlessly matching the original battery tray on boats for effortless replacement of old lead-acid batteries. The battery is equipped with the latest upgraded LiTime 5.0 Bluetooth system, allowing automatic connection to smartphones for real-time monitoring of battery status and data.

New 51.2V 100Ah Complex Home Storage Battery

Description: Upgraded from the original home storage battery, this model is more suitable for home energy storage. Its 3U server rack cabinet and customized stacking components save home storage space while being sturdier and easier to install. Designed with home use in mind, it features an intelligent touch screen and LED status lights. Its communication capabilities are seamlessly integrated with household usage, supporting industrial communication standards such as CANbus/RS485, and ensuring compatibility with a wide range of integrated MPPT charge controllers available in the market.

About LiTime

Originating from Shenzhen, China, LiTime has been a pioneer in the new energy storage field for over 15 years. Centered on user needs and driven by technological innovation, LiTime continually breaks new ground to provide the best value lithium iron phosphate batteries. As a leader in the industry, LiTime is dedicated to delivering green, sustainable, and efficient energy solutions while contributing to the reduction of the global carbon footprint and transforming the power grid landscape.

Media Contact
Company Name: Shenzhen LiTime Technology Co., Ltd
Contact Person: Shafee Chang
Email: Send Email
Country: China
Website: https://www.litime.com/

Instant Restaurant Websites Introduces Smart Solution for Restaurant Owners to Attract More Customers

New Platform Boosts Online Visibility and Reduces Costs for Restaurants

Instant Restaurant Websites has launched a new platform designed to help restaurants enhance their online presence affordably. This service allows restaurant owners to create professional, feature-rich websites in minutes, addressing the challenge of maintaining an affordable online presence in the hospitality industry.

The increasing importance of a strong online presence for restaurants has become evident in recent years. Being ranked at the top of Google is critical to the success of any local restaurant. However, many restaurant owners find professional web design services prohibitively expensive, putting them at a disadvantage in the digital marketplace. Instant Restaurant Websites aims to bridge this gap by providing an accessible, user-friendly tool that makes effective digital marketing attainable for restaurants of all sizes.

William Chase, CEO of Instant Restaurant Websites, explained the company’s mission: “We’ve seen firsthand how smaller restaurants struggle to compete online. Our goal is simple: give every restaurant the chance to shine on the web, regardless of their tech skills or budget. It’s about leveling the playing field and helping good food find its audience.”

The Instant Restaurant Websites platform offers a range of features tailored to the restaurant industry:

● Quick setup process, allowing restaurants to launch their sites rapidly

● Choose from ready-made restaurant websites that are customized to your needs

● Restaurants pay a small monthly subscription fee instead of forking over thousands of dollars to a web design company

● Cost-effective alternative to traditional web design services

● Essential features including online menus, reservation systems, and mobile-friendly designs

● Built-in SEO tools to improve search engine visibility

● User-friendly interface suitable for those with limited technical knowledge

● Ongoing updates and support to keep websites current and effective

This platform is particularly valuable for independent restaurant owners and small chains who have previously found it challenging to establish a meaningful online presence due to limited resources. It also offers an efficient solution for marketing professionals looking to quickly enhance their clients’ digital visibility in the competitive food service sector.

The real-world impact of the platform is already evident. James Chen, owner of Spice Fusion in Portland, OR, shared his experience: “As a small business owner, I was always putting off getting a proper website because of the cost. Instant Restaurant Websites changed that for us. We now have a professional-looking site that actually brings in customers. It’s made a real difference to our bottom line.”

Looking ahead, Instant Restaurant Websites plans to continue refining its offerings. The company is exploring partnerships with food delivery services and developing more advanced analytics tools to help restaurant owners better understand and cater to their customers’ preferences.

For restaurant owners interested in boosting their online presence, more information is available at www.instantrestaurantwebsites.com.

About Instant Restaurant Websites:

Instant Restaurant Websites was born out of a simple idea: every restaurant deserves a great online presence, regardless of budget. Founded in 2023 by William Chase, a veteran web developer and food enthusiast, the company bridges the gap between high-end web design and the real needs of local eateries. They’ve streamlined the website creation process, making it both affordable and user-friendly. The team combines expertise in web technology with a deep understanding of the restaurant industry, ensuring that each site they help create not only looks good but also drives real business results. At Instant Restaurant Websites, they’re not just building websites – they’re helping to level the digital playing field for restaurants of all sizes.

Media Contact
Company Name: William Chase
Contact Person: William Chase
Email: Send Email
Country: United States
Website: http://www.instantrestaurantwebsites.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Instant Restaurant Websites Introduces Smart Solution for Restaurant Owners to Attract More Customers

The Christian in the Cult – And How to Discover Humanity in Christ, By Jim Valekis

Kharis Publishing announces the release of The Christian in the Cult: And How I Discovered Humanity in Christ, by Jim Valekis. He uses his life story to take readers deep into the culture of the Greek Orthodox Church, Herbert Armstrong’s Worldwide Church of God, and modern Evangelicalism.

Jim Valekis was born in Alabama with a “bouzouki” on his knee. His Greco-American parents raised their family as part of a thriving Greek Orthodox community in Birmingham. As a teenager captivated by the radio teachings of Herbert W. Armstrong, Valekis defied his roots and eventually followed a call to pastor in the Worldwide Church of God. When the former cult transitioned into Evangelicalism, Jim followed, continuing to pastor in Grace Communion International. Most recently, Valekis co-founded the vision for the Tipp Center, a faith-based business and resource hub, where he is the chaplain. It this rich history of faith that informs Jim’s expansive and immersive narrative in The Christian in the Cult.

Jim spent 21 years in the Worldwide Church of God, a Pasadena, California-based American church many called a cult. And spent 19 years and most of his pastoral career pastoring working to transform and replant one of its churches when this cult reformed doctrinally in 1994. He saw God turn a socially isolated commuter church into an outreaching community church, and was at least verbally acknowledged for having done so on a national website. He experienced personally what it took to transform biblically from a very non-orthodox narrow view of the Scripture to a “new covenant” biblically correct one. In the process, he learned what makes a “cult” a cult from personal experience. Jim has an amazing “insiders” story of what really happens when a universally recognized cult attempts to transform, and behind-the-scenes struggles that occur within such a culture. He also has had personal experience with how the evangelical world has “cultural” limitations that go back to a misunderstanding of what Luther intended in the Reformation. Jim is now calling for a reformation to the Reformation and a new way for being church – not just for Protestants, but Catholics and Orthodox Christians as well.

Therefore, Jim Valekis’ The Christian in the Cult – And How I Discovered Humanity in Christ uses the author’s life story to take the reader deep inside the culture of the Greek Orthodox Church, Herbert Armstrong’s Worldwide Church of God, and modern Evangelicalism. After journeying through three versions of “the only true church,” Valekis deftly invites his readers to join him in his ongoing discovery of humanity in Christ and what it can mean for the church and the world.

Here is how Andrew Manis, Emeritus Professor of History Middle at Georgia State University, Macon, Georgia, describes The Christian in the Cult: ”Millions of religious believers will clearly recognize the spiritual journey narrated by Jim Valekis in this powerful story. A son of the Greek Orthodox Church finds himself in Herbert W. Armstrong’s Worldwide Church of God, which eventually takes him into more traditional Christianity and out again. Where he ends up at the end of this fascinating pilgrimage will be a big surprise. But Valekis astutely narrates his journey and brings readers along with him to a spiritual destination that includes the whole world. In a religious and political that has become a culture war of all against all, Valekis’s final message of oneness and wholeness in Christ is a welcome antidote.”

On his part, Chuck Proudfit, who is president of At Work On Purpose, sees Jim’s work as a testament to how faith in Jesus Christ can get one grounded and stablished spiritually despite the pains of a broken world. According to him, “In your hands is a book that speaks powerfully to both the complexities of living and growing in the Church, and to the way God moves in our individual lives as believers. Through the story of author Jim Valekis, we see a riveting faith testimony passed from one generation of family to another — across cultures, continents and denominations. We experience through Jim’s journey how our Christian faith can ground us and cover us spiritually, despite a fallen world, broken relationships, and vocational volatility. Jim reminds us that while our conditions and surroundings rise and fall, our steadfast relationship with Christ is All. I commend this book to you.”

For Terry Wardle, Founder of Healing Care Ministries, it was the way Jim seamlessly interwove a complex personal story with historical and scriptural insights that resonated with him. According to him, “Jim Valekis has written a journey narrative that bends the reader continually toward wholeness in Christ. His writing is deeply personal, clearly theological, and thoroughly biblical, mining the depth of each discipline to unearth the force of God’s transforming love. There is in these pages a complex personal story, interwoven with historical and scriptural insights that can guide the reader through the fog of theological compromise to the clarity that comes when Christ alone is the Lord of life. It has been said that life is a journey of formation, with the looming question, “Into what am I being formed?” Jim Valekis shines an uncompromising light on the person of Jesus Christ and bids us to surrender to the formative power of his Presence, alive in the human heart.”

Jim holds a master’s degree in biblical studies from Earlham School of Religion. He enjoys hanging out with his wife Becky, biking, painting, and sharing (especially over Greek comfort food) how his new theological understanding connects back in profound ways with the ancient Trinitarian fabric of his Orthodox upbringing, a relational Christ-centered fabric expansive enough to include every human being.

Get a copy of this book at:

Amazon: https://www.amazon.com/dp/B0D5VVCJJ7

Video Link: https://www.youtube.com/embed/gWiC7In4K5E

Kharis Publishing, an imprint of Kharis Media LLC and a leading inspirational General Trade Book publisher is currently accepting unsolicited queries for nonfiction (self-help, memoirs, business, Christian, health and wellness) from qualified leaders, professionals, pastors, and ministers) for a limited time. “Write in a book what you see…” There are no guarantees, but it is worth a shot: https://kharispublishing.com/kp/query

Media Contact
Company Name: Kharis Media LLC
Contact Person: Samuel Flourish
Email: Send Email
Phone: (630) 909-3405
City: Aurora, Chicago
State: IL
Country: United States
Website: https://kharispublishing.com/kp/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Christian in the Cult – And How to Discover Humanity in Christ, By Jim Valekis

How to Count the Stars and Live in Wonder

Kharis Publishing announces the release of “Count the Stars” by Matthew Turner. Drawing from the life of Abraham, the author shares a personal account of how to lift your head high, count the stars, and live in wonder. He writes that, similar to Abram, this is the time to go outside your tent, lift your eyes to gaze into the heavens, and then do the impossible. “Count the Stars.”

Matthew Turner, the author of the newly released book, Count the Stars, discusses the importance of taking time to gaze into the heavens in wonder, no matter the challenge. He draws inspiration from the life of biblical Abram. In an incredible encounter with God, Abram opens his heart and shares a sincere, direct dialogue and shares his frustrations and anxieties. In shocking grace, the Lord, instead of rebuking him, calls Abram outside his tent, lifts his eyes to gaze into the heavens, and then asks him to do the impossible: Count the stars. While it was impossible for Abram to count all the stars, it was an easy task for God.

Individuals who have read the book state that it helped them to be filled with the wonder of God and His power. Others suggest that message in the book helped them to be emptied of fear and worry as they are reminded of God’s abilities. Others say that the author helped them to become grateful to have One with whom they can be honest and open. In a time when many people are leaving organized religion and abandoning regular church attendance because of concern that the demands of faith might be too restrictive, it is refreshing to see a book that helps people want to embrace God, rather than run away from Him. In fact, that was an important refrain from many people who have read the book – that “Count the Stars” made them more excited about God and the prospect of a walk of faith and hope with Him.

According to Dr. Mark Rutland, Executive Director of The National Institute of Christian Leadership, “In the unending drama of today’s culture, in the midst of modern life’s intimidating contortions, one longs for a voice of hope. Dr Matthew Turner’s newest book, Count the Stars, is a timely and a readable response, calling us to that place of intimacy with God where we can hear again, believe again and obey without fear. You’ll be blessed by this book and I recommend it.”

Here is how Dr. Sam Hemby, Professor of Leadership at the Southeastern University described his own impression of the book, “I have been a night-sky lover for a long time. Nothing is more peaceful to me than to look into the star-lit blackened backdrop of a crisp night canopy and be reminded that there is a BIG GOD… and I’m not Him! Dr. Turner’s wonderful look into the life of Abraham and God’s patient interaction with him could not be a more timely read! The dark skies of uncertainty and difficulty are all around us. But so are the stars! As you dive into Count the Stars, you will be encouraged and transformed… you will also never look into the night sky the same again!”

When asked about the potential impact of Count the Stars, Dr. Eric Speir, Academic Director, Nelson University, was rather forthright: “Dr. Matthew Turner has written a clear, simple, and concise book on how to cut through the clutter and noise to hear the voice of God for your life. This book is a must-read for anyone wanting to experience the awe and wonder of God and to experience his plans and purposes for their lives.”

Is “Count the Stars a book for everyone? Dr. Doug Beacham, General Superintendent, International Pentecostal Holiness Church, says that the message of the book is for everyone – both laity and preachers. Here is how Beacham described the book, “Matthew Turner takes us on an insightful journey with the Biblical patriarch Abraham. You will feel yourself leaving Ur of the Chaldees, struggling with Abraham and Sarah in Egypt, wondering how God will perform His promise of a child born late in life, and looking into the night sky in amazement at the magnitude of God’s promises. This is an excellent book for laity and preachers alike as we grow in our walk with the same God who called Abraham four thousand years ago. You will hear that same divine voice calling you to the exciting journey of faith.”

Dr. Matthew Turner, ordained minister, is a follower of Jesus, a husband, and father who has pastored and held multiple ministry leadership roles. He has authored several books including: Follow Him and Discipleship Journey. He also is an instructor at the Barnett College of Ministry and Theology at Southeastern University. Matthew has a BA from Jacksonville State University, a MA from Liberty University, and a DM from South University. Matthew has been married for fourteen years to his sweetheart, Anna Kate, and they have three children, Elia Kate, Edyth Ray, and Ephraim Franklin.

“Count the Stars” is available wherever books are sold, including:

Kharis Website: https://kharispublishing.com/kp/product/count-the-stars/

Amazon: https://www.amazon.com/dp/B0D68RG3D7

ABOUT KHARIS PUBLISHING

Video Link: https://www.youtube.com/embed/gWiC7In4K5E

Media Contact
Company Name: Kharis Media LLC
Contact Person: Samuel Flourish
Email: Send Email
Phone: (630) 9093405
City: Aurora, Chicago
State: IL
Country: United States
Website: https://kharispublishing.com/kp/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: How to Count the Stars and Live in Wonder

Don’t Die Before You’re Dead, by Joy Blessing

““I shouldn’t be alive – I was dead 39 minutes after suffering a sudden cardiac arrest,” Joy said. “My life was amazing before I died; now I am more alive than ever to tell my story of how the joy of the Lord has strengthened my heart to share this powerful blessing of faith, hope, joy, and prayer.””

Kharis Publishing announces the release of Don’t Die Before You’re Dead – Living with a Heart of Joy, by Joy Blessing. She was clinically dead for 39 minutes after suffering a massive cardiac arrest. Miraculously, Joy Blessing revives, and survives to tell her incredible story for the first time.

As Damar Hamlin collapsed on the football field during a televised broadcast, millions were in shock when learning this physically fit young athlete suffered cardiac arrest. Immediately, a medical team surrounded him administering CPR and utilizing a defibrillator which saved his life.

Just months before Hamlin suffered from cardiac arrest witnessed by millions, Joy Blessing died from the same in a car witnessed only by her daughter who was driving, and her 7-year-old grandson who was sitting behind her. Hamlin was resuscitated within minutes, while Joy was clinically dead for more than half an hour.

However, both suffered from broken hearts, literally, that in different ways were because of a fractured world. Thankfully, both were blessed with miraculous healing through the love, faith, prayers of others, and the thoughtful care of medical personnel.

While the medical underlying causes of heart problems are complex and well-studied, it is nevertheless true that a happy heart contributes to a healthy heart, while a broken spirit can make the heart sick. It has become evident that it was not just sickness and illnesses that result in broken hearts; but psychological problems and increasingly magnified social isolation and emotional stress of our broken world play an important role as well. This is not to suggest in any way that either Damar Hamlin or Joy Blessing’s heart problems were caused by isolation or lack of joy.

Joy Blessings writes that while it may not be possible to change everything in this broken world that causes broken hearts, more can be done to help prevent heart failure caused by emotional stress. Gifts and flowers are wonderful to help comfort those working through grief and hardships, but no material possessions can prevent or heal a broken heart. Most cherished and needed for a healthy heart are the gifts of joy, love, kindness, laughter, and fun. A happy heart is a healthy heart. The most effective cure for a broken heart is time with the ones you love. It is this kind of joy, even in the face of adversity, that Joy advocates passionately from her lived experience throughout the book.

Don’t Die Before You’re Dead is Joy Blessing’s miracle story of hope in God’s plan and purpose for those who trust in Him. “I shouldn’t be alive; I was dead 39 minutes after suffering a sudden cardiac arrest,” Joy said. She continued, “We must never give up being and becoming all God created us to be. Regardless of what we go through, we can be confident God is faithful to complete the good work He begins in us.” Joy’s life was amazing before she died; now she’s more alive than ever and shares her “story of how the joy of the Lord has strengthened my heart to share this powerful blessing of faith, hope, joy, and prayer.” She added, “God’s power that raised me from the dead is the same power that inspires us to never give up, to live victoriously and purposefully, and to always believe in His faithfulness to work all things together for good for those who love Him and are called according to His purpose.”

Therefore, it is not surprising that Don’t Die Before You’re Dead has been well received by readers across the nation. According to Tim Heibel, Airline Captain, “I met Joy Blessing when I was a junior airline pilot. Joy was a flight attendant. Before the flight, I had seen her name on the paperwork and thought to myself, Joy Blessing, there has to be a story there. Was there ever a story! Her book is yet another amazing part of the story of Joy Blessing. It’s an amazing testimony of the trials and tribulations, being tested yet living a fully dedicated life of faith, and even through the tough times remaining Joy-Full! Her journey through life, and 39 minutes of death, and life again has given Joy a miraculous and amazing testimony that will bless you.”

Additionally, Claire Croskey, a retired Emergency Medical Technician, has this to say about this book of hope, “What a wonderful insight into the power of prayer and believing in the Bible! What Joy experienced on that day should open up one’s eyes to the Glory of God. The power of believing that if you follow the word of God on this earth, when you are called home, your soul will be welcomed in Heaven. This world is definitely a constant battle of evil (the devil) and good.”

When asked about her impression about this story of hope and salvation in Joy’s book, Karen Hembrough, a Medical Missionary to Guatemala, has this to say, “In this this death to life true story, God manifests His power to heal and restore the human body. The narrative is about a woman who died and was brought back to life in unusual circumstances. This piece magnifies God’s grace and mercy of the miraculous. It shows us that the Lord has a destiny for each one of our lives. The epic is extraordinarily well written. If you want an inspiring and thrilling saga of despair to victory, this book will move you to expect hope.”

Don’t Die Before You’re Dead – Living with a Heart of Joy is published by Kharis Publishing is now available wherever books are sold, inclduing:

Kharis Website: https://kharispublishing.com/kp/product/dont-die-before-youre-dead/

Amazon: https://www.amazon.com/dp/B0D5WY58T5

About Kharis Publishing

Video Link: https://www.youtube.com/embed/gWiC7In4K5E

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Don\’t Die Before You\’re Dead, by Joy Blessing

His Eye is on the Sparrow – A Remarkable Story of Resilience, By David & Ani Pearman

“”The story you are about to read is one of survival, determination and God’s sovereignty. But maybe most important, it is a story of forgiveness. Dave Pearman’s story will inspire you to forgive, to survive life’s hardest times, and to know that God has a plan.” – Rev. Jeff Hartensveld, DD, director, Asia Pacific, Assembly of God World Missions”

Kharis Publishing announces the release of His Eye Is on the Sparrow by David & Ani Pearman. Some stories may bring so much pain when they are lived, and yet bring so much healing when they are told. His Eye Is on the Sparrow is just that kind of story.

His Eye Is on the Sparrow recounts the remarkable journey of Juhn Joong Ki, from a polio-stricken Korean orphan to the resilient figure of faith, David Pearman. Despite abandonment and abuse in Korea and America, his story is a powerful testament to the human spirit’s ability to overcome adversity through faith and forgiveness. David invites readers to find echoes of their own stories within his words. Beyond a simple autobiography, David offers insight into personal transformation and spiritual awakening, and also reflects universal struggles and the power of redemption. Key highlights of His Eye is on the Sparrow include overcoming adversity and disability; growing from loss to love; exploring identity and belonging, and finding inspiration through forgiveness and faith.

David Pearman is a mechanical engineer turned educator who embodies resilience and faith through his remarkable life odyssey from a Korean orphanage to an American home. His story showcases his triumph over trials through unwavering faith. As a man of faith, David was compelled to share his spiritual testament of God’s hand in his life. His narrative is a beacon of hope, demonstrating the power of forgiveness and redemption in shaping one’s destiny. Ani Pearman, his devoted wife and co-author, brings a unique perspective to their shared passion for sharing David’s story. Her deep insights from meticulous research and her background in cross-cultural experiences enrich David’s story with empathetic understanding. Ani’s compassionate viewpoint adds a nurturing lens to David’s journey of faith, resilience, and transformation.

Many people have found David’s story very uplifting. According to Jodi Detrick, coach and author, “Some stories which bring so much pain when they are lived, nonetheless bring so much healing when they are told. His Eye is on the Sparrow is one of those powerful, poignant stories. No child should have to endure what Dave Pearman endured. It is a testament to the strength of his character and courage, and especially to the providential grace and kindness of God, that Dave’s hard journey, with all its twists and turns, is one that offers hope to the rest of us. This broken world, and maybe even your hurting heart, needs this healing story.”

Additionally, Rev. John W. Taylor, lead pastor at Surabaya International Christian Assembly, has this to say about His Eye is on the Sparrow: “At a time when headlines are replete with misery and pain, this gripping, true story turns a narrative of suffering upside down, revealing hope. This riveting autobiography tells the story of an orphan who overcomes tragedy, trauma, and pain to become a successful husband, father, and businessman. Dave Pearman’s story is the answer to the question: “Does God respond to human suffering?” Starting with the first chapter, this story will grab you, crush you, suck you in, and take you on a page-turning journey toward redemption and faith.”

On his own part, Rev. Jeff Hartensveld, director, Asia Pacific, Assembly of God World Missions, was very direct about what he thought about David’s story, “The story you are about to read is one of survival, determination and God’s sovereignty. But maybe most important, it is a story of forgiveness. Dave Pearman’s story will inspire you to forgive, to survive life’s hardest times, and to know that God has a plan.”

Even people in distant countries like Indonesia are finding David’s story truly life-giving to them. According toRev. Dave Kenney who works at the International English Service (IES), Jakarta, Indonesia, “David Pearman’s inspiring story of an amazing life journey crosses cultural lines and shows how God’s love transforms and heals in every situation. A “must read” book for anyone. I recommend it to everyone.”

His Eye is on the Sparrow is published by Kharis Publishing, an imprint of Kharis Media LLC, and is now available wherever books are sold, including:

Kharis Website: https://kharispublishing.com/kp/product/his-eye-is-on-the-sparrow/

Amazon: https://www.amazon.com/dp/B0D5X259N9

About Publishing

Video Link: https://www.youtube.com/embed/gWiC7In4K5E

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: His Eye is on the Sparrow – A Remarkable Story of Resilience, By David & Ani Pearman